)
Ecolab (ECL) investor relations material
Ecolab Investor Day 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Strategic direction
Preserve the service-led, recurring-revenue model while using technology, biotech and high tech to accelerate growth, improve margins and enter new markets.
High Tech targets semiconductor manufacturing and data centers; its addressable market was presented as $30B today, growing to $60B by 2030.
Growth engines represent 20% of sales today and are projected to exceed 50% of revenue by 2036; historical long-term organic growth was 3%–4%.
Total addressable market is projected to expand from $190B in 2026 to $330B by 2036; Global High Tech TAM carries an illustrative 15% CAGR for 2026–2036.
Growth platforms and markets
Global High Tech targets $4B sales and 25% operating margin by 2030, versus ~$1.5B annualized sales in 2026; the $4B target was described as a floor.
Ovivo ultrapure water and recycling solutions can reduce fab freshwater use by 80%, improve chip yield by 1% and deliver $100M of value per fab.
CoolIT adds direct liquid cooling; combining cooling, monitoring and service expands the sales opportunity per data center by 3x–5x versus the prior offer.
Life Sciences targets 10%–12% sales growth and 30% operating margin by 2030, versus 22% in 2026F; sales grew 7x since 2017.
Life Sciences' $15B market is supported by biologics, AI-enabled drug discovery and pharma manufacturing investment in the U.S. and Europe.
One Ecolab operating model
Shared customer data and coordinated field and operations teams identify best-in-class performance and support cross-selling; large-account revenue opportunity is $4.5B.
Customer value delivered is targeted to rise from $15B in 2026F to $18B by 2030, including $3.5B across the top 35 accounts and $1B in local opportunities.
Digital sales and service tools target 20% more field time in 2027; a 10% sales-growth opportunity has been achieved, with a goal to double it in 2027 while keeping headcount flat or slightly higher.
Agentic AI, process automation and a six-center delivery network support a $500M annualized operating expense savings target by 2030, up from $325M; program cost rises to $600M by 2030 from $425M by 2027.
- Pricing and reopening-driven growth lifted Q2 earnings despite higher costs and freeze impacts.ECL
Q2 2021 - Organic sales grew 7% as adjusted EPS rose; acquisition costs lifted leverage.ECL
Q3 2026 - Double-digit EPS growth and raised 2026 outlook, driven by strong sales and acquisitions.ECL
Q2 2026 - Strong growth, high margins, and innovation drive robust financial and shareholder returns.ECL
Investor presentation - Growth engines, innovation, and acquisitions drive strong sales, margin expansion, and returns.ECL
46th Annual William Blair Growth Stock Conference - Board elections, record financials, and AI-driven growth strategy highlighted; governance proposal rejected.ECL
AGM 2026 - 2026 outlook projects double-digit EPS growth, margin expansion, and strong organic sales.ECL
Q4 2025 - Q3 organic sales up 4%, adjusted EPS up 19%, and guidance raised 27–29% for the year.ECL
Q3 2024 - Record sales, margin gains, and double-digit 2025 EPS growth expected despite FX headwinds.ECL
Q4 2024
)
)
)
)
)
)
)
)